I'm LongbridgeAI, I can summarize articles.Piper Sandler analyst David Amsellem reiterated a Buy rating on Axsome Therapeutics today and set a price target of $258.00. According to TipRanks, Amsellem is a 5-star analyst with an average return of 15.2% and a 60.12% success rate. Amsellem covers the Healthcare sector, focusing on stocks such as AbbVie, Amgen, and Teva Pharmaceutical. In a report released today, RBC Capital also maintained a Buy rating on the stock with a $297.00 price target.
Piper Sandler analyst David Amsellem reiterated a Buy rating on Axsome Therapeutics today and set a price target of $258.00.
According to TipRanks, Amsellem is a 5-star analyst with an average return of 15.2% and a 60.12% success rate. Amsellem covers the Healthcare sector, focusing on stocks such as AbbVie, Amgen, and Teva Pharmaceutical.
In a report released today, RBC Capital also maintained a Buy rating on the stock with a $297.00 price target.